Vigil Neuroscience Stock Market Value
VIGL Stock | USD 3.60 0.10 2.70% |
Symbol | Vigil |
Vigil Neuroscience Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.11) | Return On Assets (0.40) | Return On Equity (0.70) |
The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vigil Neuroscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vigil Neuroscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vigil Neuroscience.
09/14/2024 |
| 11/13/2024 |
If you would invest 0.00 in Vigil Neuroscience on September 14, 2024 and sell it all today you would earn a total of 0.00 from holding Vigil Neuroscience or generate 0.0% return on investment in Vigil Neuroscience over 60 days. Vigil Neuroscience is related to or competes with Cullinan Oncology, Aerovate Therapeutics, Structure Therapeutics, Nuvectis Pharma, Lyra Therapeutics, Gossamer Bio, and Inhibrx. Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for ... More
Vigil Neuroscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vigil Neuroscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vigil Neuroscience upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 3.34 | |||
Information Ratio | 0.0372 | |||
Maximum Drawdown | 27.54 | |||
Value At Risk | (5.54) | |||
Potential Upside | 7.82 |
Vigil Neuroscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vigil Neuroscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vigil Neuroscience's standard deviation. In reality, there are many statistical measures that can use Vigil Neuroscience historical prices to predict the future Vigil Neuroscience's volatility.Risk Adjusted Performance | 0.0686 | |||
Jensen Alpha | 0.1158 | |||
Total Risk Alpha | (0.53) | |||
Sortino Ratio | 0.0453 | |||
Treynor Ratio | 0.2535 |
Vigil Neuroscience Backtested Returns
As of now, Vigil Stock is slightly risky. Vigil Neuroscience owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0351, which indicates the firm had a 0.0351% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Vigil Neuroscience, which you can use to evaluate the volatility of the company. Please validate Vigil Neuroscience's Coefficient Of Variation of 1271.75, semi deviation of 2.96, and Risk Adjusted Performance of 0.0686 to confirm if the risk estimate we provide is consistent with the expected return of 0.12%. Vigil Neuroscience has a performance score of 2 on a scale of 0 to 100. The entity has a beta of 1.22, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vigil Neuroscience will likely underperform. Vigil Neuroscience right now has a risk of 3.43%. Please validate Vigil Neuroscience downside variance, and the relationship between the sortino ratio and accumulation distribution , to decide if Vigil Neuroscience will be following its existing price patterns.
Auto-correlation | -0.16 |
Insignificant reverse predictability
Vigil Neuroscience has insignificant reverse predictability. Overlapping area represents the amount of predictability between Vigil Neuroscience time series from 14th of September 2024 to 14th of October 2024 and 14th of October 2024 to 13th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vigil Neuroscience price movement. The serial correlation of -0.16 indicates that over 16.0% of current Vigil Neuroscience price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.16 | |
Spearman Rank Test | -0.03 | |
Residual Average | 0.0 | |
Price Variance | 0.02 |
Vigil Neuroscience lagged returns against current returns
Autocorrelation, which is Vigil Neuroscience stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vigil Neuroscience's stock expected returns. We can calculate the autocorrelation of Vigil Neuroscience returns to help us make a trade decision. For example, suppose you find that Vigil Neuroscience has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Vigil Neuroscience regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vigil Neuroscience stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vigil Neuroscience stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vigil Neuroscience stock over time.
Current vs Lagged Prices |
Timeline |
Vigil Neuroscience Lagged Returns
When evaluating Vigil Neuroscience's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vigil Neuroscience stock have on its future price. Vigil Neuroscience autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vigil Neuroscience autocorrelation shows the relationship between Vigil Neuroscience stock current value and its past values and can show if there is a momentum factor associated with investing in Vigil Neuroscience.
Regressed Prices |
Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Vigil Neuroscience Correlation, Vigil Neuroscience Volatility and Vigil Neuroscience Alpha and Beta module to complement your research on Vigil Neuroscience. For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Vigil Neuroscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.